Intranasal beta-agonist in allergic rhinitis.
Holt
S
S
Wellington Asthma Research Group, Wellington School of Medicine, New Zealand. shaunh@wnmeds.ac.nz
Suder
A
A
Dronfield
L
L
Holt
C
C
Beasley
R
R
D000281:Administration, Intranasal; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D000068759:Formoterol Fumarate; D006801:Humans; D008297:Male; D008875:Middle Aged; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D000068759:Formoterol Fumarate